A randomized study assessing efficacy of the phenotype-directed use of mepolizumab reduces the rate of asthma exacerbations in urban children
Latest Information Update: 19 Apr 2023
At a glance
- Drugs Mepolizumab (Primary) ; Corticosteroids
- Indications Asthma; Eosinophilia
- Focus Therapeutic Use
Most Recent Events
- 27 Feb 2023 Results assessing the efficacy of mepolizumab in urban children with asthma, presented at the 2023 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
- 11 Apr 2022 New trial record
- 28 Feb 2022 Results of an analysis aiming to identification of specific airway inflammatory pathways can lead to effective personalized treatment with biologics in asthma and insights to mechanisms of action presented at the 2022 Annual Meeting of the American Academy of Allergy, Asthma and Immunology